Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05998642 |
| Title | Ibrutinib Combination Therapy in Transplant Ineligible Individuals With Newly Diagnosed Primary CNS Lymphoma |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Canadian Cancer Trials Group |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | CAN |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| BCCA - Vancouver | RECRUITING | Vancouver | British Columbia | V5Z 4E6 | Canada | Details |
| Ottawa Hospital Research Institute | RECRUITING | Ottawa | Ontario | K1H 8L6 | Canada | Details |
| University Health Network | RECRUITING | Toronto | Ontario | M5G 2M9 | Canada | Details |
| The Research Institute of the McGill University | NOT_YET_RECRUITING | Montreal | Quebec | H4A 3J1 | Canada | Details |
| CHU de Quebec-Hopital l'Enfant-Jesus (HEJ) | RECRUITING | Quebec City | Quebec | G1J 1Z4 | Canada | Details |